Impact of licence change on co-proxamol mortality in Scotland

被引:0
|
作者
Sandilands, E. A. [1 ]
Bateman, D. N. [1 ]
机构
[1] Royal Infirm Edinburgh NHS Trust, Scottish Poisons Informat Bur, NPIS Edinburgh, Edinburgh, Midlothian, Scotland
关键词
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
168
引用
收藏
页码:389 / 389
页数:1
相关论文
共 50 条
  • [31] 12 years on: Co-proxamol revisited (vol 347, pg 1840, 1996)
    Haigh
    [J]. LANCET, 1996, 348 (9023): : 346 - 346
  • [32] Pain Relief Medication Following Cessation of Co-Proxamol Use: An Analysis Using the GPRD
    Irvine, David
    Petersen, Jakob
    Wise, Lesley
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S111 - S112
  • [33] Co-Proxamol (Distalgesic) Procurement in Bahrain Policy Implications for Gulf Cooperation Council Countries
    Al Khaja, K. A. J.
    [J]. MEDICAL PRINCIPLES AND PRACTICE, 2009, 18 (03) : 253 - 254
  • [34] LIVER-FUNCTION IN PATIENTS ON LONG-TERM PARACETAMOL (CO-PROXAMOL) ANALGESIA
    HUTCHINSON, DR
    SCHILDS, AF
    PARKE, DV
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1986, 38 (03) : 242 - 243
  • [35] THE PHARMACOKINETICS OF DEXTROPROPOXYPHENE AND NORDEXTROPROPOXYPHENE AFTER SINGLE AND MULTIPLE DOSES OF CO-PROXAMOL IN YOUNG AND ELDERLY VOLUNTEERS
    CROME, P
    FLANAGAN, RJ
    WHITE, AST
    JOHNSTONE, A
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1988, 36 (07) : 661 - 661
  • [36] Six-Year Follow-Up of Impact of Co-proxamol Withdrawal in England and Wales on Prescribing and Deaths: Time-Series Study
    Hawton, Keith
    Bergen, Helen
    Simkin, Sue
    Wells, Claudia
    Kapur, Navneet
    Gunnell, David
    [J]. PLOS MEDICINE, 2012, 9 (05):
  • [37] Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: time series analysis
    Hawton, Keith
    Bergen, Helen
    Simkin, Sue
    Brock, Anita
    Griffiths, Clare
    Romeri, Ester
    Smith, Karen L.
    Kapur, Navneet
    Gunnell, David
    [J]. BRITISH MEDICAL JOURNAL, 2009, 338 : 435 - 437
  • [38] Is killing pain worth the risk? MPs argue that the regulator went too far when it banned co-proxamol
    Coombes, Rebecca
    [J]. BRITISH MEDICAL JOURNAL, 2007, 334 (7586): : 186 - 187
  • [39] Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol (vol 315, pg 1565, 1997)
    Po, LW
    Zhang
    [J]. BRITISH MEDICAL JOURNAL, 1998, 316 (7132): : 656 - 656
  • [40] Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol (vol 315, pg 1565, 1997)
    Po, ALW
    Zhang, WY
    [J]. BRITISH MEDICAL JOURNAL, 1998, 316 (7125): : 116 - 116